Vertex unveils promising VX-222/Incivek combo data in HCV
26 July 2011
Mike Ward
Please Login to read the full article.
26 July 2011
Mike Ward
Please Login to read the full article.
RELATED CONTENT
NEWS
- Alios banks $60 million in HCV nucleotide analogue deal with Vertex
- First Hep C protease head-to-head trial pits Medivir's TMC435 against J&J's telaprevir
- Anadys's positive Phase IIb hep C data for setrobuvir tempered by moving SoC
- Stockwatch: Humans – the weak link in drug development
ANALYSIS
Other Informa Analysis
FEATURES
Other Informa Features
EVENTS
07 June 2012
The Rembrandt Hotel, London
12 June 2012
Annecy, France
18 June 2012
Boston Convention & Exhibition Center, Boston, MA
JOB OF THE WEEK
Section Head (m/f)
DRA International/CIS Section
Section Head (m/f)
DRA International/CIS Section
